ZUMA-7: Clinical Implications

Author(s):

Matthew Lunning, DO, FACPAnn Mohrbacher, MD

Experts review some of the safety outcomes from the ZUMA-7 trial as well as discussing the clinical implications of the ZUMA-7 trial into their practice.

EP: 1.Front-Line Treatment Options for Patients with DLBCL

EP: 2.An Overview of R/R DLBCL

EP: 3.Treatment Options for Patients with R/R DLBCL

EP: 4.L-MIND: Review of Long-Term Analyses Data

EP: 5.Role of CAR T-cell Therapy in Patients with R/R DLBCL

EP: 6.Eligibility Criteria for CAR T-Cell Therapy in R/R DLBCL

Now Viewing

EP: 7.ZUMA-7: Clinical Implications

EP: 8.Sequencing Therapies in Patients with R/R DLBCL

EP: 9.Potential Role of CAR T-cell Therapy in the Front-line Setting for Patients with R/R DLBCL

EP: 10.Future of R/R DLBCL

Latest Conference Coverage

Experts Weigh in on Topic of Frontline Osimertinib Alone or With Chemo in EGFR-Mutant NSCLC

Dr Sands on the Evolving Role of ADCs in SCLC Management

Dr Hirsch on the Treatment of NRG1 Fusion+ NSCLC

MRD Testing Requires Prospective Data to Assess Clinical Utility in Breast Cancer

View More Latest Conference Coverage

Do Not Sell My Information

Contact Info

2 Commerce Drive
Cranbury, NJ 08512